Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
22,010,623
-
Shares change
-
+2,992,905
-
Total reported value, excl. options
-
$384,380,000
-
Value change
-
+$52,268,047
-
Number of buys
-
47
-
Number of sells
-
-16
-
Price
-
$17.46
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2020
75 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,010,623 shares
of 51,368,292 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4,187,801 shares), FRAZIER MANAGEMENT LLC (3,566,912 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,448,912 shares), Novo Holdings A/S (2,445,147 shares), Rock Springs Capital Management LP (1,496,525 shares), BAKER BROS. ADVISORS LP (647,313 shares), VANGUARD GROUP INC (627,796 shares), BlackRock Inc. (554,889 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (544,341 shares), and Sio Capital Management, LLC (494,743 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.